Bellevue Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $172K | Sell |
1,250
-1,400
| -53% | -$192K | ﹤0.01% | 129 |
|
|
2025
Q1 | $478K | Sell |
2,650
-2,397
| -47% | -$432K | 0.01% | 117 |
|
|
2024
Q4 | $791K | Buy |
5,047
+268
| +6% | +$42K | 0.02% | 122 |
|
|
2024
Q3 | $870K | Buy |
4,779
+581
| +14% | +$106K | 0.01% | 122 |
|
|
2024
Q2 | $771K | Sell |
4,198
-612
| -13% | -$112K | 0.01% | 123 |
|
|
2024
Q1 | $856K | Sell |
4,810
-3,190
| -40% | -$568K | 0.01% | 124 |
|
|
2023
Q4 | $992K | Sell |
8,000
-4,500
| -36% | -$558K | 0.02% | 122 |
|
|
2023
Q3 | $1.45M | Sell |
12,500
-5,500
| -31% | -$638K | 0.02% | 117 |
|
|
2023
Q2 | $2.11M | Sell |
18,000
-300
| -2% | -$35.2K | 0.03% | 113 |
|
|
2023
Q1 | $1.47M | Hold |
18,300
| – | – | 0.02% | 121 |
|
|
2022
Q4 | $1.45M | Hold |
18,300
| – | – | 0.02% | 129 |
|
|
2022
Q3 | $1.28M | Buy |
18,300
+4,900
| +37% | +$342K | 0.02% | 131 |
|
|
2022
Q2 | $880K | Sell |
13,400
-400
| -3% | -$26.3K | 0.01% | 138 |
|
|
2022
Q1 | $918K | Sell |
13,800
-200
| -1% | -$13.3K | 0.01% | 151 |
|
|
2021
Q4 | $979K | Buy |
+14,000
| New | +$979K | 0.01% | 156 |
|